Drug sensitivity and the resistance rate (drug susceptibility and gene analysis) were investigated in 5,720 strains of
Streptococcus pneumoniae detected in the nasopharynx of children with upper airway infection who visited our hospital between 2003 and 2007. Changes in penicillin G sensitivity of
S. pneumoniae showed biphasic peaks every year, but the peaks in 2003 to 2005 were 0.12 and 2.0 μg/ml, while those in 2006 and 2007 were 0.06 and 2.0 μg/ml, showing a change. Regarding the resistance rate presented as rates of PSSP, PISP, and PRSP, the rate of PRSP exceeded 50% in 2003, but decreased to about 37% in 2007, while the rate of PSSP was lower than 10% in 2003, but exceeded 25% in 2007. The reduction of the rate of RPSP and increase in the rate of PSSP were marked after, compared to those before 2006. The combined rate of conversion to resistance of PRSP and PISP exceeded 90% in 2003, but decreased to slightly below 75% in 2007. On investigation of pbp gene mutation, strains showing mutation of all pbp1a, 2b, and 2x genes (gPRSP) were the most frequently detected, accounting for about 60%. However, the rate decreased with time from nearly 70% in 2003 to below 60% in 2007. Strains with mutations of pbp2x, pbp1a+2x, and pbp2b+2x accounted for about 10%, respectively. Almost all strains exhibited pbp gene mutation (gPSSP) in 2003, but the rate of strains without this mutation increased to nearly 10% in 2007. Changes in erythromycin sensitivity showed biphasic peaks every year. One peak was lower than 0.12 μg/ml, and the other was higher than 2.0 μg/ml. The rate of strains with a less than 0.12 μg/ml sensitivity tended to decrease, while that of strains with sensitivity higher than 2.0 μg/ml tended to increase. Regarding the resistance rate, the rates of erythromycin susceptible
S. pneumoniae (EMSSP), erythromycin-intermediate resistant
S. pneumoniae (EMISP), and erythromycin resistant
S. pneumoniae (EMRSP) did not change in any year, and EMSSP accounted for about 13%, EMISP for about 2%, and EMRSP for about 85%. On the detection of macrolide resistance genes, mefA and ermB, strains with only ermB were the most frequently detected, accounting for about 40–50%, in all years, those with mefA alone accounted for about 30%, those with neither gene accounted for 10–15%, and those with both mefA and ermB accounted for about 5–15%. The rate of strains with neither gene did not change, but those with mefA alone decreased with time, and those with ermB alone and both mefA and ermB increased.
View full abstract